AtaiBeckley Inc., a clinical-stage biotech company focused on mental health treatments, announced its management will participate in several investor conferences in June 2026, including events in New York, Miami, and virtual formats. The company will present updates on its pipeline, which includes therapies for treatment-resistant depression and social anxiety disorder, with key drugs in Phase 2 and Phase 3 development stages. These presentations aim to inform investors about ongoing progress and future plans in advancing innovative mental health therapies. Live and archived webcasts will be available for broader investor access.
Invesco's Board of Trustees announced dividend declarations for multiple closed-end funds, with distributions reported on Form 1099-DIV for federal tax purposes. The exact tax character of these dividends will be finalized after 2026 ends. Dividend a...
Vallourec, a global leader in premium tubular solutions, announced a webcast event titled 'Vallourec Geothermal Deep Dive' scheduled for June 15, 2026, at 5:00 PM CET. The webcast will feature insights from Philippe Guillemot, CEO, and Bertrand de Ro...
Ondas Inc. reported $30 million in new orders for its unmanned and autonomous systems, pushing Q2 bookings above $110 million and expanding its backlog in defense and security technologies. The company posted a strong Q1 revenue of $50.1 million, sig...
Orano Canada and Cameco have agreed to acquire TEPCO Resources' 5% stake in the Cigar Lake uranium mine, increasing Orano's ownership to 42.582% and Cameco's to 57.418%. This move strengthens their partnership and commitment to low-carbon nuclear ene...
The National Advertising Division (NAD) upheld Spectrum's claim that customers can receive free high-speed internet forever by purchasing and maintaining four mobile lines. However, NAD recommended that Spectrum clearly disclose key terms, such as th...
